RxNT, a leader in eHealth technology, announced today the launch of their EPCS-Certified E-Prescribing mobile application for Android (the “RxNT Android App”). The release of RxNT’s Android App marks the first EPCS-Certified Android Application to the market. The application has all of the robust functionality of RxNT’s EPCS-Certified Desktop E-Prescribing solution, but now users can safely and securely prescribe controlled substances on-the-go.
Electronic prescribing of controlled substances (EPCS) helps to reduce fraud and improve safety and patient care. EPCS and e-prescribing remain top of mind as the New York State mandate for electronic prescribing goes into effect on March 27, 2015. Further, the DEA’s increase in the control of certain drugs, such as Hydrocodone continues to emphasize the importance of securely prescribing controlled substances. RxNT’s EPCS-Certified Android Application fills the need in the marketplace for a safer and more secure solution.
RxNT designed their app with usability and mobility in mind. The RxNT Android app is packed with features to reduce errors and fraud, two key benefits to electronically prescribing controlled substances.
Several of the features that demonstrate the mobility and precision of the RxNT Android app include:
- Provider verification of all information before prescription submission
- Auto-populated medication instructions for prescriptions
- Prescription Status (success, pending, error, fail)
- Favorite pharmacy settings on the doctor and patient level
The RxNT Android App streamlines prescribing for doctors and patients alike, improving patient satisfaction overall. Interested readers are invited to call an RxNT Sales Representative at 1-800-943-7968 to request literature and a complimentary product demonstration.
The launch of the RxNT Android App follows RxNT’s recent enhanced RxNT Apple App iOS release.
The RxNT Android App can be downloaded free of charge from the Google Play Store and can be used along with RxNT’s EPCS-Certified Desktop E-Prescribing solution.